Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Eli Lilly's marginal cancer drug becomes Exhibit A in pricing debate
Eli Lilly's marginal cancer drug becomes Exhibit A in pricing debate
Eli Lilly's marginal cancer drug becomes Exhibit A in pricing debate
Submitted by
admin
on August 29, 2015 - 8:56am
Source:
Fierce Biotech
News Tags:
Eli Lilly
drug pricing
necitumumab
non-small cell lung cancer
Headline:
Eli Lilly's marginal cancer drug becomes Exhibit A in pricing debate
Do Not Allow Advertisers to Use My Personal information
